Leveraging Immunologic Pathways in the Management of Patients With Psoriatic Arthritis or Axial Spondyloarthritis: Clinical Pearls for the Advanced Practice Provider
Released On
March 3, 2025
Expires On
March 3, 2026
Media Type
Internet
Completion Time
70 minutes
Specialty
Psoriasis, Rheumatology
Topics
Arthritis, Axial Spondyloarthritis, axSpa, Psoriatic Arthritis, Rheumatoid Arthritis
This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Lilly.
Credit Available
- Physicians — 1.0 AMA PRA Category 1 Credits™
- Nurses — 1.0 ANCC contact hour
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This CME initiative is designed to meet the educational needs of advanced practice providers, both physician assistants and nurse practitioners who specialize in rheumatology, involved in the care of patients with psoriatic arthritis and axial spondyloarthritis.
Program Overview
This program is designed to improve the ability of advanced practice professionals to take a treat-to-target approach to managing patients with axial spondyloarthritis (axSpA) conditions.
Learning Objectives
- Identify patients with active disease to prevent delays in treatment escalation to achieve low disease activity or remission
- Develop patient-specific treatment regimens for individuals with PsA and axSpA by advancing through Biologic DMARD (bDMARD) options
- Apply evidence-based guidelines in the treat-to-target management of patients with PsA or axSpA
Faculty
Wendy Wright Simmons, PA-C, DFAAPA
Carolina Arthritis Associates
Wilmington, NC
Joint Accreditation Statement
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nursing (ANCC) Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosures of Conflicts of Interest
Wendy Wright Simmons, PA-C, DFAAPA
Consultant: AbbVie, Amgen, Boehringer Ingelheim, Fresenius Kabi, Lilly, and Radius Health
Speakers Bureau: AbbVie, Amgen, Boehringer Ingelheim, Johnson & Johnson, Pfizer, Radius Health, Sanofi, and UCB
Instructions for Participation and Credit
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CE questions, please contact Med Learning Group at: [email protected].
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
